Skip to main content

GeneDx to Launch Clinical Exome Sequencing Test in Early 2012


GeneDx is planning an early 2012 launch for XomeDx, a clinical exome sequencing test, the Bio-Reference Laboratories subsidiary said this week.

The test, expected to be available starting in January, is aimed at patients with genetic diseases where more targeted genetic tests were unable to provide a molecular diagnosis.

The Gaithersburg, Md.-based company will run the test in its CLIA-certified laboratory and will apply its clinical expertise, technology, and analysis of family data to identify the genetic defect. It will generate test reports that "will be simple to understand for the clinician, patient, and their family."

The test would join a similar offering from Ambry Genetics, which last week launched its Clinical Diagnostic Exome test for patients with undiagnosed or difficult-to-diagnose genetic disorders (CSN 10/5/2011).

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.